FDA New, GMP Do
Clinical Phase II, III Intermediates
GMP Custom synthesis, Full Document
R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web: www.eosmedchem.com
Email: info@eosmedchem.com; eosmedchem@gmail.com
This is my R&D youtube: https://youtu.be/r5cJdXKNXHk
Clinical Phase II, III Intermediates
GMP Custom synthesis, Full Document
R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web: www.eosmedchem.com
Email: info@eosmedchem.com; eosmedchem@gmail.com
This is my R&D youtube: https://youtu.be/r5cJdXKNXHk
ELB-139, 188116-08-7, ELB-139 Intermediate 32549-33-0, stock 720.8g, white powder, assay by HPLC 98.3%, HNMR, LCMS we supply. |
ELB-139, 188116-08-7, ELB-139 Intermediate 110-89-4, stock 791.9g, white powder, assay by HPLC 98.9%, HNMR, LCMS we supply. |
ELB-139, 188116-08-7, ELB-139 Intermediate 188116-08-7, stock 961.9g, white powder, assay by HPLC 99.4%, HNMR, LCMS we supply. |